Alpha-synuclein A53T
3 findings
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
What did studies of alpha-synuclein A53T find?
3Studies of alpha-synuclein A53T measured 3 outcomes: inflammation, SATB1 and cellular senescence.
Inflammation
upin mice1
1 study
Inflammation
upin mice1
Alpha-synuclein A53T increases inflammation in mice (AAV-mediated overexpression).
“overexpression of α-synuclein-A53T (α-syn-A53T) for 1 week not only induced a pro-inflammatory phenotype in nigral microglia”
AnimalsAAV-mediated overexpressionnigral microglia1 week
Acta pharmacologica Sinica
SATB1
downin mice1
1 study
SATB1
downin mice1
Alpha-synuclein A53T decreases SATB1 in mice (AAV2/9-mediated overexpression).
“evidenced by reduced SATB1 expression along with increased levels of γ-H2A.X and p21 in TH-positive dopaminergic neurons”
AnimalsAAV2/9-mediated overexpressionAAV2/9 vector encoding human α-syn-A53TTH-positive dopaminergic neurons1 week
Acta pharmacologica Sinica
Cellular senescence
upin mice1
1 study
Cellular senescence
upin mice1
Alpha-synuclein A53T increases cellular senescence in mice (AAV2/9-mediated overexpression).
“α-syn-A53T promoted senescence in nigral dopaminergic neurons via the SATB1/DNA damage/p21 signaling pathway”
AnimalsAAV2/9-mediated overexpressionAAV2/9 vector encoding human α-syn-A53Tnigral dopaminergic neurons1 week
Acta pharmacologica Sinica